Clinical Trial
Interventions for Postoperative Delirium
Study Description
“Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)”
The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
Procedure - High Density-Electroencephalogram
Additional Information
Official Study Title
Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2) Pilot Study
Clinical Trial ID
NCT02926417
ParticipAid ID
RdG7Jd
